45 filings
Page 2 of 3
8-K
1z6xq21ffs rl5l0gf
19 Aug 22
Kymera Announces $150 Million Private Placement Equity Financing
7:59am
8-K
tn2fwvek0
9 Aug 22
Kymera Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Business Update
7:10am
8-K
v57u7k
8 Jul 22
Departure of Directors or Certain Officers
7:45am
8-K
ibas5p7
16 Jun 22
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
acy4xm3e
3 May 22
Kymera Therapeutics Announces First Quarter 2022 Financial Results and Provides a Business Update
7:10am
8-K
xb5ssm8im
11 Apr 22
Departure of Directors or Certain Officers
4:16pm
8-K
qd04klvha2mfqergsjvz
24 Feb 22
Kymera Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides a Business Update
7:10am
8-K
thmx8feroysfug4dzl0
18 Jan 22
Departure of Directors or Certain Officers
4:06pm
8-K
d8m908f 5p
27 Dec 21
Entry into a Material Definitive Agreement
4:09pm
8-K
794km hz0su7
16 Dec 21
Other Events
7:12am
8-K
24fo951g
10 Nov 21
Kymera Therapeutics Announces Third Quarter 2021 Financial Results and Provides a Business Update
7:16am
8-K
uksbfbf
27 Oct 21
Regulation FD Disclosure
9:02am
8-K
e4awehuec0lwi0
16 Sep 21
Departure of Directors or Certain Officers
4:02pm
8-K
vtyoygtijkltyjyojdm
6 Aug 21
Kymera Therapeutics Announces Second Quarter 2021 Financial Results and Provides a Business Update
7:10am
8-K
5a3uwf6bn
28 Jun 21
Kymera Therapeutics Announces Positive Interim Results from Single Ascending Dose Phase 1 Trial of KT-474 Demonstrating Degrader Proof-of-Mechanism
7:46am
8-K
98y39
17 Jun 21
Submission of Matters to a Vote of Security Holders
4:41pm
8-K
mys5m00w
6 May 21
Kymera Therapeutics Announces First Quarter 2021 Financial Results and Provides a Business Update
7:10am
8-K
67buh
16 Mar 21
Departure of Directors or Certain Officers
4:15pm
8-K
orif g511ewfj
11 Mar 21
Kymera Therapeutics Announces Fourth Quarter and Full Year 2020 Financial
7:09am
8-K
ao2a723n25e346aq
2 Mar 21
KT-474 is the first IRAK4 degrader, and first heterobifunctional small molecule protein degrader outside of oncology, to enter clinical development
7:15am